Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 42, 2023 - Issue 1
160
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Systemic eosinophilic disease presenting as dacryoadenitis

, , , & ORCID Icon
Pages 107-111 | Received 29 Jun 2021, Accepted 22 Aug 2021, Published online: 12 Sep 2021

References

  • Akella SS, Schlachter DM, Black EH, Barmettler A. Ophthalmic eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a systematic review of the literature. Ophthalmic Plast Reconstr Surg. 2019;35(1):7–16. doi:10.1097/IOP.0000000000001202.
  • Walford HH, Doherty TA. Diagnosis and management of eosinophilic asthma: a US perspective. J Asthma Allergy. 2014;7:53–65.
  • Knop E, Knop N. Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system. Ophthalmologe. 2003;100(11):929–942. doi:10.1007/s00347-003-0936-6.
  • Radice A, Bianchi L, Sinico RA. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev. 2013;12(4):487–495. doi:10.1016/j.autrev.2012.08.008.
  • Corren J. Inhibition of interleukin-5 for the treatment of eosinophilic diseases. Discov Med. 2012;13:305–312.
  • Drick N, Seeliger B, Welte T, Fuge J, Suhling H. Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment response. BMC Pulm Med. 2018;18(1):119. doi:10.1186/s12890-018-0689-2.
  • Buggage RR, Spraul CW, Wojno TH, Grossniklaus HE. Kimura disease of the orbit and ocular adnexa. Surv Ophthalmol. 1999;44(1):79–91. doi:10.1016/S0039-6257(99)00064-8.
  • Kanazawa S, Gong H, Kitaoka T, Amemiya T. Eosinophilic granuloma (Kimura’s disease) of the orbit: a case report. Graefe’s Arch Clin Exp Ophthalmol. 1999;237(6):518–521. doi:10.1007/s004170050272.
  • Azari AA, Kanavi MR, Lucarelli M, Lee V, Lundin AM, Potter HD, et al. Angiolymphoid hyperplasia with eosinophilia of the orbit and ocular adnexa: report of 5 cases. JAMA Ophthalmol. 2014;132(5):633–636. doi:10.1001/jamaophthalmol.2013.8243.
  • Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460–1471. doi:10.1016/S0140-6736(14)60720-0.
  • Benlemlih A, Szableski V, Bendahou M, Rivière S, Villain M, Costes V. Fibrose angiocentrique à éosinophiles: une manifestation de la maladie systémique liée au IgG4? [Eosinophilic angiocentric fibrosis: a form of IgG4-related systemic disease?]. Ann Pathol. 2012;32(4):271‐5. doi:10.1016/j.annpat.2012.06.008.
  • Padhi TR, Das S, Sharma S, Rath S, Rath S, Tripathy D, et al. Ocular parasitoses: a comprehensive review. Surv Ophthalmol. 2017;62(2):161–189. doi:10.1016/j.survophthal.2016.09.005.
  • Das JK, Gupta K, Deshmukh S, Shrivastava R. A rare case of hypereosinophilic syndrome presenting with unilateral proptosis and torticollis. Indian J Ophthalmol. 2018;66(10):1508–1511. doi:10.4103/ijo.IJO_316_18.
  • Zenone T, Ligeon-Ligeonnet P. Hypereosinophilic syndrome and orbital inflammatory pseudotumor. Presse Med. 2005;34(16 Pt 1):1141–1142. doi:10.1016/S0755-4982(05)84138-7.
  • Sivak-Callcott JA, Rootman J, Rasmussen SL, Nugent RA, White VA, Paridaens D, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90(5):602–608. doi:10.1136/bjo.2005.085894.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.